Siu Ling Chan
Direttore/Membro del Consiglio presso Logic Express Ltd.
Profilo
Siu Ling Chan is currently a Director at Logic Express Ltd.
Previously, Chan was the Chairman at China Biologic Products, Inc. from 2006 to 2012.
Before that, Chan was a Director at Shandong Taibang Biological Products Co. Ltd.
Chan's earlier work experience includes being an Administrator at Fujian Academy of Social Sciences from 2005 to 2005.
Chan received an undergraduate degree from Xiamen University in 1989.
Posizioni attive di Siu Ling Chan
Società | Posizione | Inizio |
---|---|---|
Logic Express Ltd.
Logic Express Ltd. Pharmaceuticals: MajorHealth Technology Part of China Biologic Products Holdings, Inc., Logic Express Ltd. is a British company that produces plasma-based pharmaceutical products. The company is based in Basingstoke, UK. Logic Express was acquired by China Biologic Products, Inc. on July 19, 2006. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Siu Ling Chan
Società | Posizione | Fine |
---|---|---|
Fujian Academy of Social Sciences | Direttore Amministrativo | 01/01/2005 |
Shandong Taibang Biological Products Co. Ltd.
Shandong Taibang Biological Products Co. Ltd. BiotechnologyHealth Technology Part of China Biologic Products Holdings, Inc., Shandong Taibang Biological Products Co. Ltd. is a Chinese company that manufactures and wholesales biological products. The company is based in Tai'an, China. The company was founded in 2002. Guang Li Pang has been the CEO of the company since 2002. | Direttore/Membro del Consiglio | - |
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Presidente | 03/04/2012 |
Formazione di Siu Ling Chan
Xiamen University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
Shandong Taibang Biological Products Co. Ltd.
Shandong Taibang Biological Products Co. Ltd. BiotechnologyHealth Technology Part of China Biologic Products Holdings, Inc., Shandong Taibang Biological Products Co. Ltd. is a Chinese company that manufactures and wholesales biological products. The company is based in Tai'an, China. The company was founded in 2002. Guang Li Pang has been the CEO of the company since 2002. | Health Technology |
Logic Express Ltd.
Logic Express Ltd. Pharmaceuticals: MajorHealth Technology Part of China Biologic Products Holdings, Inc., Logic Express Ltd. is a British company that produces plasma-based pharmaceutical products. The company is based in Basingstoke, UK. Logic Express was acquired by China Biologic Products, Inc. on July 19, 2006. | Health Technology |
Fujian Academy of Social Sciences |
- Borsa valori
- Insiders
- Siu Ling Chan